1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 26 JANUARY 2015

Cancer Drug News 26 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - CAR-T Market Gaining Traction
Industry Brief - EC Favours Iclusig's Approved Indications Throughout Europe
Industry Brief - Hybrigenics Launches Inecalcitol Phase II Study In CML
Industry Brief - Curis/Aurigene Collaborate To Develop Immuno-Oncology/Precision Oncology Targets
Industry Brief - Celator's CPX-351 Gains FDA Fast Track Designation
Industry Brief - BioInvent Reaches Agreement For BI-1206 Phase I/II Trial In CLL/NHL
Industry Brief - Milestone Triggered As Novartis' Jakavi Gains CHMP Positive Opinion For Polycythaemia Vera
Industry Brief - Theravectys Secures Grant From Bpifrance
Industry Brief - Qu Biologics Initiates Phase IIa Trial Of QBKPN SSI In NSCLC
Industry Brief - CHMP Adopts Positive Opinion On Abraxane For First-Line NSCLC
Industry Brief - Verastem's VS-5584 Gains EC Orphan Designation For Mesothelioma
Industry Brief - ESSA Raises Funds To Complete EPI-506 Phase I/II PCA Programme
Industry Brief - Enzalutamide Phase II MCRPCA Trial Meets Primary Endpoint
Industry Brief - Aprea Granted EU Orphan Designation For APR-246 In OC
Industry Brief - Karcinolys' Oncolytic Virus Myb34.5 Gains US/EU Orphan Designations In PC
Industry Trend Analysis - ASCO GI 2014 Indicates Future Market For Hard-To-Treat Upper GI Tract Cancers
Industry Brief - Provectus Granted Chinese Patent Allowance For Rose Bengal Synthesis
Industry Brief - Tiziana Licenses Milciclib From Nerviano
Industry Brief - PCI Biotech's US Amphinex Phase II Programme Receives FDA Approval
Industry Trend Analysis - Undulations In CytRx' Share Price To Continue Until Release Of More Definitive Data
Industry Brief - MedImmune/NCI Enter Partnership To Advance Oncology Research
Industry Brief - Array To Acquire Global Rights To Encorafenib From Novartis
Industry Trend Analysis - Clovis To Transform As Pipeline Matures
Industry Brief - Enrolment Begins In Gem's Phase II Trial Of GPX-150 In Soft Tissue Sarcoma
Industry Brief - CytRx' Aldoxorubicin Phase IIb STS Trial Results Have Room For Improvement
Industry Brief - BMG Grants Distribution Rights To Ferrer For GelX Rinse/Spray

Table Of Contents

Cancer Drug News 26 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.